Bhalchandra Rao
Pre-clinical discovery biologist, Biomarker and Translational Sciences, New targets and drug modalities, Rare disease advocate, Innovator and RNA enthusiast
- Role
- Director, Translational Research at International Rett Syndrome Foundation
- Location
- Cambridge, MA, US
- LinkedIn followers
- 500 followers
About Bhalchandra Rao
Accomplished RNA biology leader with 15+ years of expertise at the intersection of molecular biology, biochemistry, and drug discovery — with a track record of translating mechanistic insight into therapeutic impact across oncology and neurology. Throughout a career spanning both biotech and nonprofit science leadership, I have architected and led end-to-end drug discovery programs — from target identification and validation through cellular platform development — establishing rigorous Go/No-Go decision frameworks that accelerate pipeline efficiency and de-risk investment. My command of cutting-edge genetic modalities, including ASO, CRISPR-based systems, siRNA, and RNA-protein interaction platforms, has enabled the systematic interrogation of novel RNA-targeting opportunities and the discovery of first-in-class drug candidates. As a people leader, I have built and mentored high-performing research teams, cultivating cultures of scientific rigor, intellectual curiosity, and cross-functional collaboration. I thrive at the interface of science and strategy — translating complex biological insights into actionable decisions that align with organizational priorities and timelines. In my current role as a research investment strategist at IRSF, I direct a ~$2M grant portfolio with a focus on maximizing translational impact in Rett Syndrome. I have rapidly built a high-value ecosystem of KOL relationships spanning clinical, academic, and industry stakeholders — leveraging these partnerships to shape the field\'s research agenda and accelerate the path from discovery to patient benefit.
Experience
Director, Translational Research
International Rett Syndrome Foundation
Oct 2025 — Present · Boston, MA, US
Domain Expertise: Rapidly acquired deep expertise in Rett syndrome biology and the therapeutic landscape on an accelerated timeline, enabling credible engagement with top-tier scientific, clinical, and industry stakeholders.Strategy & Analysis: Conducted a comprehensive SWOT analysis of the Rett syndrome research and drug development landscape; translated findings into strategic investment recommendations adopted by leadership for fiscal years 2026 and 2027, prioritizing programs with the highest probability of impact for patients.Program Initiation: Initiated a multi-stakeholder biomarker collaboration (academia, industry, and CRO) to address a critical unmet need in Rett syndrome—a rare neurological disease—directly supporting future clinical trial readiness and therapeutic development.KOL & Partnership Engagement: Forged and cultivated strategic partnerships with academic and industry KOLs across the US and globally, expanding IRSF’s scientific influence and advancing its mission for patients and caregivers.Portfolio Management: Managed IRSF’s $2M research funding portfolio, overseeing grant disbursements, financial oversight, and scientific milestone reporting across multiple funded investigators to ensure alignment with organizational objectives.
Education
Ramnarain Ruia College
Bachelor of Science (B.Sc.), Microbiology, General
2001 — 2004
The Maharaja Sayajirao University of Baroda
Master of Science (M.Sc.), Biochemistry
2004 — 2006
The Ohio State University
Doctor of Philosophy (Ph.D.), Biochemistry and Molecular Biology
2007 — 2014
Find verified contacts for anyone on LinkedIn
Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.
Free plan included · No credit card required
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.